April 26, 2016 9:14 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at Piper Jaffray downgraded
Sarepta Therapeutics Inc (NASDAQ: SRPT) from Neutral to Underweight. The target price for Sarepta Therapeutics has been lowered from $15 to $6. Sarepta Therapeutics shares fell 47.49 percent to $7.85 in pre-market trading.Bank of America downgraded
Canadian National Railway (USA) (NYSE: CNI) from Buy to Underperform. Canadian National Railway shares closed at $65.18 on Monday.Analysts at Deutsche Bank downgraded
U.S. Bancorp (NYSE: USB) from Buy to Hold. US Bancorp shares closed at $43.05 on Monday.Evercore ISI Group downgraded
Zions Bancorporation (NASDAQ: ZION) from Buy to Hold. Zions Bancorp shares dropped 2.57 percent to $26.59 in pre-market trading.Analysts at Cantor Fitzgerald downgraded
Whiting Petroleum Corp (NYSE: WLL) from Buy to Hold. Whiting Petroleum shares closed at $11.07 on Monday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.